$992 Million is the total value of Vivo Capital, LLC's 44 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 20.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CDXS | Sell | Codexis, Inc. | $47,151,000 | +7.2% | 2,749,343 | -10.0% | 4.75% | -16.2% |
FIXX | Sell | Homology Medicines, Inc. | $26,512,000 | -7.8% | 1,159,742 | -17.7% | 2.67% | -27.9% |
MEIP | Sell | MEI Pharma Inc (NAS) | $24,904,000 | -4.2% | 5,778,106 | -12.5% | 2.51% | -25.1% |
APLS | Sell | Apellis Pharmaceuticals, Inc. | $24,084,000 | -24.8% | 1,354,554 | -7.0% | 2.43% | -41.2% |
SELB | Sell | Selecta Biosciences, Inc. | $11,837,000 | +14.4% | 761,253 | -2.5% | 1.19% | -10.5% |
DCPH | Sell | Deciphera Pharmaceuticals In | $8,234,000 | -17.3% | 212,648 | -15.9% | 0.83% | -35.3% |
SBBP | Sell | Strongbridge Biopharma plc | $4,453,000 | -61.3% | 918,132 | -52.1% | 0.45% | -69.7% |
FOMX | Sell | Foamix Pharmaceuticals Ltd. | $2,450,000 | -42.8% | 427,500 | -50.0% | 0.25% | -55.3% |
RGNX | Exit | Regenxbio Inc. | $0 | – | -82,403 | -100.0% | -0.76% | – |
MDGL | Exit | Madrigal Pharmaceuticals Inc | $0 | – | -62,220 | -100.0% | -2.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
CODEXIS INC | 29 | Q3 2023 | 8.0% |
ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
AMYRIS INC | 23 | Q3 2023 | 8.8% |
EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-22 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-08 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.